Hemostemix ( $HEM) develops autologous cell therapies, notably ACP-01, for critical limb ischemia. Opening at $0.055, their stock shows promising trends with moving averages and consistent trading volumes. #stock #investor #dailytrading #stockMarket #Trader $MCBC $BACK $WISA
0
0
0
173
0
Download Image